Sight-Threatening Graves’ Ophthalmopathy during the Third Trimester of Pregnancy: A Case Report-Reference-Cited by-同舟云学术

Sight-Threatening Graves’ Ophthalmopathy during the Third Trimester of Pregnancy: A Case Report

Published:2020 Issue:4 Volume:252 Page:321-327
ISSN:0040-8727
Container-title:The Tohoku Journal of Experimental Medicine
language:en
Short-container-title:Tohoku J. Exp. Med.

Author:

Sakurai Kanako¹,Inoue Toshu²,Niitsuma Satsuki¹,Sato Ryota¹,Takahashi Kazuhiro³,Arihara Zenei¹

Affiliation:

1. Department of Endocrinology and Metabolism, National Hospital Organization Sendai Medical Center

2. Olympia Eye Hospital

3. Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine

Publisher

Tohoku University Medical Press

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/tjem/252/4/252_321/_pdf

Reference49 articles.

1. Abbouda, A., Trimboli, P. & Bruscolini, A. (2014) A mild Grave’s ophthalmopathy during pregnancy. Semin. Ophthalmol., 29, 8-10.

2. Alkawas, A.A., Hussein, A.M. & Shahien, E.A. (2010) Orbital steroid injection versus oral steroid therapy in management of thyroid-related ophthalmopathy. Clin. Exp. Ophthalmol., 38, 692-697.

3. Allannic, H., Fauchet, R., Orgiazzi, J., Madec, A.M., Genetet, B., Lorcy, Y., Le Guerrier, A.M., Delambre, C. & Derennes, V. (1990) Antithyroid drugs and Graves’ disease: a prospective randomized evaluation of the efficacy of treatment duration. J. Clin. Endocrinol. Metab., 70, 675-679.

4. Anderson, G.G., Rotchell, Y. & Kaiser, D.G. (1981) Placental transfer of methylprednisolone following maternal intravenous administration. Am. J. Obstet. Gynecol., 140, 699-701.

5. Bahn, R.S. (2010) Graves’ ophthalmopathy. N. Engl. J. Med., 362, 726-738.